Shares Bazaar

Cipla Ltd.

NSE   0.00  
OPEN PRICE(₹)
0.00
HIGH PRICE(₹)
0.00
LOW PRICE(₹)
0.00
CLOSE PRICE(₹)
0.00
VOLUME
0.00
52 WK LOW (₹)
355.3 (13-03-2020)
52 WK HIGH (₹)
878.9 (03-02-2021)
BSE   882.95  
OPEN PRICE₹)
894.45
HIGH PRICE(₹)
895.1
LOW PRICE (₹)
877.6
CLOSE PRICE(₹)
882.95
VOLUME
274097
VALUE
243100000
BID QTY
0
OFFER QTY
0

Stock Summary

Trade Value (₹ in Lacs) : 1612.92 MCap (₹ in Mn) : 678676.79 Dividend Yield(%) : 0.48 Price/Earning (TTM) : 30.26
TTM EPS (₹) : 0 Price/Sales (TTM) : 0 P/E Ratio : 0.01 Price/Book (MRQ) : 3.6
Book Value(₹) : 0 Face Value(₹) : 0 Latest Reserve (₹ in Mn): 186780.9 EPSc : 28.75
PE : 29.27 TTMNP : 22427.3 TTMTAX : 6734.6 TTMINTEREST : 446.9
TTMDEPRECIATION : 5880.9 TTMNetSales : 126106.8 EV_Sales : 5.34 EV (in Mn) : 673506.69
TTMEBITDA : 35489.7 EV_EBITDA : 18.98 TTMCashProfit : 28308.2 TTMCEPS : 35.1
Price_CEPS : 23.97 TTMNPAEX : 22427.3

Peer Group Compare

Comp. Name Price M.Cap Div Yld % P/E Ratio Price/Earning (TTM) TTM EPS (₹)
Sun Pharmaceutical Industries Ltd. (BSE)

679.5 ( 0.04%)

135418.47 0.71 0 47 12.01
Divis Laboratories Ltd. (BSE)

4029.5 ( -0.81%)

91003.96 0.47 0.06 51.76 66.23
Dr. Reddys Laboratories Ltd. (BSE)

5173.55 ( 0.15%)

81092.78 0.51 0.04 33.02 147.67
Aurobindo Pharma Ltd. (BSE)

1012.75 ( 0.42%)

55333.11 0.32 0.01 20.8 45.4
Lupin Ltd. (BSE)

1195.6 ( -0.12%)

47639.05 0.57 0.01 54.89 19.13

Management Info

Chairman : Y K Hamied
Managing Director : Umang Vohra
Company Secretory : Rajendra Chopra
Incorporation Year : 1935

Registered Office

Address : Cipla House
Peninsula Business Park
Ganpatrao Kadam Marg, Lower Parel
City-Pincode : Mumbai-400013
Phone : 022-24826000 / 022-24826951
Website : www.cipla.com
Email : cosecretary@cipla.com

Registrars Details

Registrars Details : K FIN Technologies Pvt Ltd.-(Karvy Fintech Pvt Ltd.)
Address : Karvy Selenium Tower B, Plot 31-32Gachibowli,Financial District, NanakramgudaHyderabad – 500032Tel. No. 040 67161500Fax. No. 040 23001153E-mail: einward.ris@karvy.comWebsite: www.karvy.comToll Free No. of exclusive Call Centre:1-800-345001
Listing : BSE, NSE, Luxembourg, MCX

loading..

Balance Sheet

(₹ in Million)
Particulars Mar-2020 Mar-2019 Mar-2018 Mar-2017 Mar-2016
SOURCES OF FUNDS:
Share Capital 0.16 0.16 0.16 0.16 0.16
  Equity - Authorised 0.18 0.18 0.18 0.18 0.18
  Equity - Issued 0.16 0.16 0.16 0.16 0.16
 Equity Paid Up 0.16 0.16 0.16 0.16 0.16
  Equity Shares Forfeited 0.00 0.00 0.00 0.00 0.00
  Adjustments to Equity 0.00 0.00 0.00 0.00 0.00
  Preference Capital Paid Up 0.00 0 0 0.00 0
  Face Value 0 0 0 0 0
Share Warrants & Outstandings 0.00 0.00 0.00 0.00 0.00
Total Reserves 15.55 14.79 14 12.32 11.27
  Securities Premium 1.6 1.57 1.54 1.51 1.45
  Capital Reserves -0.15 0.18 0.02 -0.04 -0.06
  Profit & Loss Account Balances 11.12 10.25 9 7.77 6.95
  General Reserves 3.14 3.14 3.14 3.14 3.14
Reserve excluding Revaluation Reserve 15.55 14.79 14 12.32 11.27
Revaluation Reserves 0.00 0 0 0.00 0
Deposits 0.00 0.00 0.00 0.00 0.00
  Demand Deposits 0.00 0.00 0.00 0.00 0.00
  Savings Deposit 0.00 0.00 0.00 0.00 0.00
  Term Deposits / Fixed Deposits 0.00 0.00 0.00 0.00 0.00
  Current Deposits 0.00 0.00 0.00 0.00 0.00
  Recurring Deposits 0.00 0.00 0.00 0.00 0.00
  Other Deposits 0.00 0.00 0.00 0.00 0.00
Borrowings 0.00 0.00 0.00 0.00 0.00
  Borrowings From Reserve Bank of India 0.00 0.00 0.00 0.00 0.00
  Borrowings From Other Banks 0.00 0.00 0.00 0.00 0.00
  Borrowings From GOI 0.00 0.00 0.00 0.00 0.00
  Borrowings From Other Financial Institutions 0.00 0.00 0.00 0.00 0.00
  Borrowings in the form of Bonds / Debentures 0.00 0.00 0.00 0.00 0.00
  Borrowings in Other Form 0.00 0.00 0.00 0.00 0.00
Other Liabilities & Provisions 0.00 0.00 0.00 0.00 0.00
  Bills Payable 0.00 0.00 0.00 0.00 0.00
  Inter-office adjustment Liabilities 0.00 0.00 0.00 0.00 0.00
  Interest Accrued 0.00 0.00 0.00 0.00 0.00
  Proposed Dividend 0.00 0.00 0.00 0.00 0.00
  Corporate dividend tax payable 0.00 0.00 0.00 0.00 0.00
  Other Liabilities & Provisions 0.13 0.12 0.14 0.14 0.14
Total Liabilities 18.9 19.77 18.53 16.91 12.38
APPLICATION OF FUNDS :
Cash and balance with Reserve Bank of India 0.00 0.00 0.00 0.00 0.00
  Cash with RBI 0.00 0.00 0.00 0.00 0.00
  Cash in hand & others 0.00 0.00 0.00 0.00 0.00
Balances with banks and money at call 0.00 0.00 0.00 0.00 0.00
Investments 2.35 3.24 2.03 1.73 1.36
Investments in India 0.00 0.00 0.00 0.00 0.00
  GOI/State Govt. Securities 0.00 0.00 0.00 0.00 0.00
  Equity Shares - Corporate 0.00 0.00 0.00 0.00 0.00
  Debentures & Bonds 0.00 0.00 0.00 0.00 0.00
  Subsidiaries and/or joint ventures/Associates 0.00 0.00 0.00 0.00 0.00
  Units - MF/ Insurance/CP/PTC 0.00 0.00 0.00 0.00 0.00
Investments outside India 0.00 0.00 0.00 0.00 0.00
  Government securitiesC 0.00 0.00 0.00 0.00 0.00
  Subsidiaries and/or joint ventures abroad 0.00 0.00 0.00 0.00 0.00
  Other investments outside India 0.00 0.00 0.00 0.00 0.00
  Less: Prov for Diminution in Value of Invest. 0.00 0.00 0.00 0.00 0.00
Advances 0.00 0.00 0.00 0.00 0.00
  Bills Purchased & Discounted 0.00 0.00 0.00 0.00 0.00
  Cash Credit, Over Draft & Loans repayable 0.00 0.00 0.00 0.00 0.00
  Term Loans 0.00 0.00 0.00 0.00 0.00
  Finance lease and hire purchase receivable 0.00 0.00 0.00 0.00 0.00
Gross block 15.01 13.79 12.96 11.37 10.17
  Premises 2.86 2.55 2.55 2.25 2.03
  Assets Given on Lease 0.00 0.00 0.00 0.02 0.00
  Other Fixed Assets 0.00 0.00 0.00 0.00 0.00
Less: Accumulated Depreciation 5.41 4.23 3.01 1.61 0.8
Net Block 9.56 9.55 9.95 9.51 9.37
Less: Impairment of Assets 0.05 0.01 0.00 0.25 0.00
Lease Adjustment 0.00 0.00 0.00 0.00 0.00
Capital Work in Progress 0.82 0.68 0.98 1.68 2.06
Other Assets 0.00 0.00 0.00 0.00 0.00
  Inter-office adjustment Assets 0.00 0.00 0.00 0.00 0.00
  Interest Accrued Assets 0.00 0.00 0.00 0.00 0.00
  Tax paid in advance/TDS 0.00 0.00 0.00 0.00 0.00
  Stationery and stamps 0.00 0.00 0.00 0.00 0.00
  Non-banking assets acquired 0.00 0.00 0.00 0.00 0.00
  Deferred tax asset 0.00 0.00 0.00 0.00 0.00
  Miscellaneous Expenditure not written off 0.00 0.00 0.00 0.00 0.00
Total Assets 18.9 19.77 18.53 16.91 12.38
Contingent Liabilities 0.76 0.82 0.77 0.87 0.48
  Claims not acknowledged as debts 0.51 0.64 0.63 0.69 0.32
  Outstanding forward exchange contracts 0.00 0.00 0.00 0.00 0.00
  Guarantees given in India 0.00 0.00 0.00 0.00 0.00
  Guarantees given Outside India 0.00 0.00 0.00 0.00 0.00
  Acceptances, endorsements & other obligations 0.00 0.00 0.00 0.00 0.00
Bills for collection 0.00 0.00 0.00 0.00 0.00
Book Value 0.19 0.19 0.18 0.16 0.14
Adjusted Book Value 0.19 0.19 0.18 0.16 0.14
(₹ in Million)
Particulars Mar-2020 Mar-2019 Mar-2018 Mar-2017 Mar-2016
SOURCES OF FUNDS:
Share Capital 0.16 0.16 0.16 0.16 0.16
  Equity - Authorised 0.18 0.18 0.18 0.18 0.18
  Equity - Issued 0.16 0.16 0.16 0.16 0.16
 Equity Paid Up 0.16 0.16 0.16 0.16 0.16
  Equity Shares Forfeited 0.00 0.00 0.00 0.00 0.00
  Adjustments to Equity 0.00 0.00 0.00 0.00 0.00
  Preference Capital Paid Up 0.00 0.00 0.00 0.00 0.00
  Face Value 0 0 0 0 0
Share Warrants & Outstandings 0.00 0.00 0.00 0.00 0.00
Total Reserves 17.21 15.58 13.9 12.58 11.74
  Securities Premium 1.6 1.57 1.54 1.51 1.45
  Capital Reserves 0 0 0 0 0
  Profit & Loss Account Balances 12.48 10.83 9.21 7.93 7.15
  General Reserves 3.14 3.14 3.14 3.14 3.14
Reserve excluding Revaluation Reserve 17.21 15.58 13.9 12.58 11.74
Revaluation Reserves 0.00 0.00 0.00 0.00 0.00
Deposits 0.00 0.00 0.00 0.00 0.00
  Demand Deposits 0.00 0.00 0.00 0.00 0.00
  Savings Deposit 0.00 0.00 0.00 0.00 0.00
  Term Deposits / Fixed Deposits 0.00 0.00 0.00 0.00 0.00
  Current Deposits 0.00 0.00 0.00 0.00 0.00
  Recurring Deposits 0.00 0.00 0.00 0.00 0.00
  Other Deposits 0.00 0.00 0.00 0.00 0.00
Borrowings 0.00 0.00 0.00 0.00 0.00
  Borrowings From Reserve Bank of India 0.00 0.00 0.00 0.00 0.00
  Borrowings From Other Banks 0.00 0.00 0.00 0.00 0.00
  Borrowings From GOI 0.00 0.00 0.00 0.00 0.00
  Borrowings From Other Financial Institutions 0.00 0.00 0.00 0.00 0.00
  Borrowings in the form of Bonds / Debentures 0.00 0.00 0.00 0.00 0.00
  Borrowings in Other Form 0.00 0.00 0.00 0.00 0.00
Other Liabilities & Provisions 0.00 0.00 0.00 0.00 0.00
  Bills Payable 0.00 0.00 0.00 0.00 0.00
  Inter-office adjustment Liabilities 0.00 0.00 0.00 0.00 0.00
  Interest Accrued 0.00 0.00 0.00 0.00 0.00
  Proposed Dividend 0.00 0.00 0.00 0.00 0.00
  Corporate dividend tax payable 0.00 0.00 0.00 0.00 0.00
  Other Liabilities & Provisions 0.11 0.11 0.12 0.13 0.13
Total Liabilities 17.67 16.01 14.36 13.05 12.25
APPLICATION OF FUNDS :
Cash and balance with Reserve Bank of India 0.00 0.00 0.00 0.00 0.00
  Cash with RBI 0.00 0.00 0.00 0.00 0.00
  Cash in hand & others 0.00 0.00 0.00 0.00 0.00
Balances with banks and money at call 0.00 0.00 0.00 0.00 0.00
Investments 7.87 6.53 5.37 5.05 4.93
Investments in India 0.00 0.00 0.00 0.00 0.00
  GOI/State Govt. Securities 0.00 0.00 0.00 0.00 0.00
  Equity Shares - Corporate 0.00 0.00 0.00 0.00 0.00
  Debentures & Bonds 0.00 0.00 0.00 0.00 0.00
  Subsidiaries and/or joint ventures/Associates 0.00 0.00 0.00 0.00 0.00
  Units - MF/ Insurance/CP/PTC 0.00 0.00 0.00 0.00 0.00
Investments outside India 0.00 0.00 0.00 0.00 0.00
  Government securitiesC 0.00 0.00 0.00 0.00 0.00
  Subsidiaries and/or joint ventures abroad 0.00 0.00 0.00 0.00 0.00
  Other investments outside India 0.00 0.00 0.00 0.00 0.00
  Less: Prov for Diminution in Value of Invest. 0.00 0.00 0.00 0.00 0.00
Advances 0.00 0.00 0.00 0.00 0.00
  Bills Purchased & Discounted 0.00 0.00 0.00 0.00 0.00
  Cash Credit, Over Draft & Loans repayable 0.00 0.00 0.00 0.00 0.00
  Term Loans 0.00 0.00 0.00 0.00 0.00
  Finance lease and hire purchase receivable 0.00 0.00 0.00 0.00 0.00
Gross block 6.56 6.09 5.75 5.15 4.27
  Premises 1.97 1.95 1.97 1.88 1.68
  Assets Given on Lease 0.00 0.00 0.00 0.00 0.00
  Other Fixed Assets 0.00 0.00 0.00 0.00 0.00
Less: Accumulated Depreciation 2.52 1.96 1.43 0.92 0.44
Net Block 4.02 4.13 4.32 4.24 3.83
Less: Impairment of Assets 0.02 0 0 0 0
Lease Adjustment 0.00 0.00 0.00 0.00 0.00
Capital Work in Progress 0.32 0.3 0.46 0.56 0.55
Other Assets 0.00 0.00 0.00 0.00 0.00
  Inter-office adjustment Assets 0.00 0.00 0.00 0.00 0.00
  Interest Accrued Assets 0.00 0.00 0.00 0.00 0.00
  Tax paid in advance/TDS 0.00 0.00 0.00 0.00 0.00
  Stationery and stamps 0.00 0.00 0.00 0.00 0.00
  Non-banking assets acquired 0.00 0.00 0.00 0.00 0.00
  Deferred tax asset 0.00 0.00 0.00 0.00 0.00
  Miscellaneous Expenditure not written off 0.00 0.00 0.00 0.00 0.00
Total Assets 17.67 16.01 14.36 13.05 12.25
Contingent Liabilities 2.83 4.55 4.29 4.36 4.12
  Claims not acknowledged as debts 0.5 0.49 0.49 0.53 0.32
  Outstanding forward exchange contracts 0.00 0.00 0.00 0.00 0.00
  Guarantees given in India 0.00 0.00 0.00 0.00 0.00
  Guarantees given Outside India 0.00 0.00 0.00 0.00 0.00
  Acceptances, endorsements & other obligations 0.00 0.00 0.00 0.00 0.00
Bills for collection 0.00 0.00 0.00 0.00 0.00
Book Value 0.22 0.2 0.17 0.16 0.15
Adjusted Book Value 0.22 0.2 0.17 0.16 0.15

Quarterly Results

Particulars Sep-2020 Jun-2020 Mar-2020 Feb-2019
Date End Audited Audited Audited Audited
Interest Earned 50382.90 43461.60 43761.90 43710.00
Income On Investments 0.00 0.00 0.00 0.00
Interest On Balances With Rbi Other Inter Bank Funds 0.00 0.00 0.00 0.00
Interest / Discount On Advances / Bills 0 0 0 0
Others 0 0 0 0
Other Income 534.7 654.5 931.8 721.3
Total Income 50917.6 44116.1 44693.7 44431.3
Interest Expended 393.3 460 530 461.7
Operating Expenses 0 0 0 0
Total Expenditure 38617.2 32974.2 37426.7 36126.7
Operating Profit Before Provisions and Contingencies 12300.4 11141.9 7267 8304.6
Exceptional Items 0 0 0 0
Provisions and contingencies 0 0 0 0
Profit Before Tax 9256.5 7992.1 3279 5064
Tax 2638 2277.8 855.9 1528.2
Profit After Tax 6618.5 5714.3 2423.1 3535.8
+/- Extraordinary Items 0 0 0 0
+/- Prior period items 0 0 0 0
Net Profit 6618.5 5714.3 2423.1 3535.8
Minority Interest 60.8 118.7 74.6 116.5
Shares of Associates -25 -53.9 -38.2 -142
Other related items 0 0 0 0
Misc. Expenses Written off 0.00 0.00 0.00 0.00
Consolidated Net Profit 6618.5 5714.3 2423.1 3535.8
Equity Capital 6654.3 5779.1 2459.5 3510.3
Face Value (IN RS) 2 2 2 2
Reserves 0 0 0 0
% of Shares held by Govt 0 0 0 0
Capital Adequacy Ratio 0.00 0.00 0.00 0.00
Gross / Net NPAs 0.00 0.00 0.00 0.00
Amount of Gross NPAs 0.00 0.00 0.00 0.00
Amount of Net NPAs 0 0 0 0
% of Gross / Net NPAs NA NA NA NA
% of Net NPAs 0 0 0 0
% of Gross NPAs 0 0 0 0
Return on Assets 0 0 0 0
No of Public Share Holdings NA NA NA NA
% of Public Share Holdings NA NA NA NA
Basic Eps After Extraordinary Items 8.25 7.17 3.05 4.35
Basic Eps Before Extraordinary Items 8.25 7.17 3.05 4.35
PBIDTM% 24.41 25.64 16.61 19
PBDTM% 23.63 24.58 15.39 17.94
PBTM% 18.37 18.39 7.49 11.59
PATM% 13.14 13.15 5.54 8.09
Particulars Sep-2020 Jun-2020 Mar-2020
Date End Audited Audited Audited
Interest Earned 38078.9 31280.2 31334.4
Income On Investments 0 0 0
Interest On Balances With Rbi Other Inter Bank Funds 0 0 0
Interest / Discount On Advances / Bills 0 0 0
Others 0.00 0.00 0.00
Other Income 391.7 456.6 4134.1
Total Income 38470.6 31736.8 35468.5
Interest Expended 116.9 142.1 92.4
Operating Expenses 0.00 0.00 0.00
Total Expenditure 26769.2 21832.8 26686.4
Operating Profit Before Provisions and Contingencies 11701.4 9904 8782.1
Exceptional Items 0 0 0
Provisions and contingencies 0.00 0.00 0.00
Profit Before Tax 10176.5 8324.6 7085.5
Tax 2720.1 2221.6 1039.8
Profit After Tax 7456.4 6103 6045.7
+/- Extraordinary Items 0.00 0.00 0.00
+/- Prior period items 0.00 0.00 0.00
Net Profit 7456.4 6103 6045.7
Minority Interest 0.00 0.00 0.00
Shares of Associates 0.00 0.00 0.00
Other related items 0.00 0.00 0.00
Misc. Expenses Written off 0.00 0.00 0.00
Consolidated Net Profit 7456.4 6103 6045.7
Equity Capital 7456.4 6103 6045.7
Face Value (IN RS) 2 2 2
Reserves 0 0 0
% of Shares held by Govt 0.00 0.00 0.00
Capital Adequacy Ratio 0.00 0.00 0.00
Gross / Net NPAs 0.00 0.00 0.00
Amount of Gross NPAs 0.00 0.00 0.00
Amount of Net NPAs 0.00 0.00 0.00
% of Gross / Net NPAs NA NA NA
% of Net NPAs 0.00 0.00 0.00
% of Gross NPAs 0.00 0.00 0.00
Return on Assets 0.00 0.00 0.00
No of Public Share Holdings NA NA NA
% of Public Share Holdings NA NA NA
Basic Eps After Extraordinary Items 9.25 7.57 7.5
Basic Eps Before Extraordinary Items 9.25 7.57 7.5
PBIDTM% 30.73 31.66 28.03
PBDTM% 30.42 31.21 27.73
PBTM% 26.72 26.61 22.61
PATM% 19.58 19.51 19.29

Profit-Loss

-
Particulars Mar-2020 Mar-2019 Mar-2018 Mar-2017 Mar-2016
I. INCOME
Interest Earned 0 0 0 0 0
     Interest / Discount on advances / Bills 0 0 0 0 0
     Interest on balances with RBI and other Inter-bank funds 0 0 0 0 0
     Income on investments 0 0 0 0 0
     Others 0 0 0 0 0
Other Income
     Commission,exchange and brokerage 0 0 0 0 0
     Profit / (loss)on sale of investments(net) 0.13 0.19 0.15 0.18 0.06
     Profit on sale of Fixed Assets 0 0 0.02 0 0.01
     Foreign Exchange Gains 0.1 0.04 0.02 0 0.1
     Income earned from subsidiaries/joint venture 0 0 0 0 0
     Rent / Lease Income
     Provisions Written Back 0 0.03 0 0.01 0.01
     Miscellaneous income -1108.14 -1429.71 -1072.95 -228.69 -624.63
Total Income 17.5 16.84 15.51 14.62 13.8
II. EXPENDITURE
Interest Expended 0.2 0.17 0.11 0.16 0.21
     Intereston Deposits 0 0 0 0 0
     Interest on RBI / inter-bank borrowings 0 0 0 0 0
     Other Interest 0.04 0.01 0.11 0.16 0.21
Operating Expenses 0 0 0 0 0
     Payments to and provisions for employees 3.03 2.86 2.69 2.63 2.43
     Rent,Taxes and lighting 0.13 0.18 0.16 0.15 0.15
     Depreciation on Banks property 1.1 1.1 0.95 1.32 0.75
     Depreciation on leased assets
     Auditor's fees and expenses 0 0 0 0 0.01
     Law charges 0.7 0.5 0.45 0.35 0.29
     Communication Expenses 0.03 0.04 0.04 0.04 0.04
     Repairs and Maintenance 0 0 0 0 0
     Insurance 0.05 0.04 0.03 0.04 0.03
     Other expenses -5.04 -4.71 -4.32 -4.54 -3.7
Provisions and Contingencies
     Provision for investments
     Provision for advances
     Others Provisions
Profit Before Tax 17.3 16.67 15.4 14.46 13.6
Taxes
     Current Income Tax 0.68 0.75 0.55 0.48 0.47
     Deferred Tax -0.31 -0.23 -0.2 -0.11 -0.14
     Other taxes 0 0 0 0 0
Profit After Tax 1.55 1.51 1.42 1.04 1.4
Extra items
Minority Interest 0.05 0.04 -0.01 -0.03 -0.02
Share of Associate -0.05 -0.02 -0 -0.01 -0.01
Other Consolidated Items
Consolidated Net Profit 1.55 1.53 1.41 1.01 1.36
Adjustments to PAT 0.01
IV. APPROPRIATIONS
     Transfer to Statutory Reserve
     Appropriation to General Reserve
     Appropriation to Revenue Reserve
     Appropriation to Other Reserves 0.3 0.28 0.19 0.19 0.01
     Equity Dividend 0.16
     Corporate dividend tax 0.05 0.02
     Other appropriations 11.44 10.25 9 7.77 6.95
Equity Dividend % 200.00 150.00 150.00 100.00 100.00
Earnings Per Share 19.1816 18.9612 17.5199 12.5095 16.9279
Adjusted EPS 19.1816 18.9612 17.5199 12.5095 16.9279
-
Particulars Mar-2020 Mar-2019 Mar-2018 Mar-2017 Mar-2016
I. INCOME
Interest Earned 0 0 0 0 0
     Interest / Discount on advances / Bills 0 0 0 0 0
     Interest on balances with RBI and other Inter-bank funds 0 0 0 0 0
     Income on investments 0 0 0 0 0
     Others 0 0 0 0 0
Other Income
     Commission,exchange and brokerage 0 0 0 0 0
     Profit / (loss)on sale of investments(net) 0.11 0.11 0.08 0.04 0.08
     Profit on sale of Fixed Assets 0 0 0.01 0 0.01
     Foreign Exchange Gains 0.12 0.02 0.02 0 0.07
     Income earned from subsidiaries/joint venture 0 0 0 0 0
     Rent / Lease Income
     Provisions Written Back 0 0.03 0 0.01 0.01
     Miscellaneous income -2741.28 -1732.56 -1004.64 -259.7 -840.9
Total Income 13.57 12.95 11.72 10.9 12.23
II. EXPENDITURE
Interest Expended 0.04 0.02 0.01 0.04 0.15
     Intereston Deposits 0 0 0 0 0
     Interest on RBI / inter-bank borrowings 0 0 0 0 0
     Other Interest 0.04 0.02 0.01 0.04 0.15
Operating Expenses 0 0 0 0 0
     Payments to and provisions for employees 1.91 1.84 1.79 1.73 1.78
     Rent,Taxes and lighting 0.07 0.09 0.08 0.08 0.09
     Depreciation on Banks property 0.58 0.56 0.53 0.5 0.44
     Depreciation on leased assets
     Auditor's fees and expenses 0 0 0 0 0
     Law charges 0.56 0.43 0.43 0.4 0.59
     Communication Expenses 0.02 0.03 0.03 0.03 0.03
     Repairs and Maintenance 0 0 0 0 0
     Insurance 0.03 0.02 0.02 0.02 0.02
     Other expenses -3.17 -2.96 -2.87 -2.76 -2.96
Provisions and Contingencies
     Provision for investments
     Provision for advances
     Others Provisions
Profit Before Tax 13.54 12.93 11.71 10.86 12.08
Taxes
     Current Income Tax 0.55 0.58 0.42 0.31 0.36
     Deferred Tax -0.15 -0.03 0.01 0.08 -0.07
     Other taxes 0 0 0 0 0
Profit After Tax 2.32 1.89 1.47 0.97 1.46
Extra items
Minority Interest
Share of Associate
Other Consolidated Items
Consolidated Net Profit 2.32 1.89 1.47 0.97 1.46
Adjustments to PAT
IV. APPROPRIATIONS
     Transfer to Statutory Reserve
     Appropriation to General Reserve
     Appropriation to Revenue Reserve
     Appropriation to Other Reserves 0.29 0.27 0.19 0.19 0.01
     Equity Dividend 0.16
     Corporate dividend tax 0.05 0.02
     Other appropriations 12.8 10.83 9.21 7.93 7.15
Equity Dividend % 200 150 150 100 100
Earnings Per Share 28.75 23.44 18.24 12.12 18.20
Adjusted EPS 28.75 23.44 18.24 12.12 18.20

Financial Ratios

Particulars Mar-2020 Mar-2019 Mar-2018 Mar-2017 Mar-2016
Operational & Financial Ratios
Earnings Per Share (Rs) 19.18 18.96 17.52 12.51 16.93
DPS(Rs) 4 3 3 2 2
Book NAV/Share(Rs) 194.85 185.62 175.92 155.15 142.23
Margin Ratios
Yield on Advances 0 0 0 0 0
Yield on Investments 0 0 0 0 0
Cost of Liabilities 0 0 0 0 0
NIM 0 0 0 0 0
Interest Spread 0 0 0 0 0
Performance Ratios
ROA(%) 6.56 6.5 6.52 4.97 7.28
ROE(%) 10.09 10.37 10.65 8.72 12.61
ROCE(%) 12.53 11.94 10.2 8.28 13.24
Efficiency Ratios
Cost Income Ratio 0 0 0 0 0
Core Cost Income Ratio 0 0 0 0 0
Operating Costs to Assets 0 0 0 0 0
Capital Adequacy
Basel I
Total CAR (Basel I) 0 0 0 0 0
Tier-1 (Basel I) 0 0 0 0 0
Tier-2 (Basel I) 0 0 0 0 0
Basel II
Total CAR (Basel II) 0 0 0 0 0
Tier-1 (Basel II) 0 0 0 0 0
Tier-2 (Basel II) 0 0 0 0 0
Basel III
Total CAR (Basel III) 0 0 0 0 0
Tier - 1 (Basel III) 0 0 0 0 0
Tier - 2 (Basel III) 0 0 0 0 0
Valuation Parameters
PER(x) 22.05 27.91 31.01 47.35 30.26
PCE(x) 12.88 16.36 18.46 20.15 19.14
Price/Book(x) 2.17 2.85 3.09 3.82 3.6
Yield(%) 0.95 0.57 0.55 0.34 0.39
EV/Net Sales(x) 2.1 2.83 3.09 3.55 3.35
EV/Core EBITDA(x) 10.33 13.86 16.67 18.9 16.92
EV/EBIT(x) 15.12 20.62 26.28 37.01 23.52
EV/CE(x) 1.53 1.95 2.07 2.45 2.16
M Cap / Sales 1.99 2.61 2.89 3.31 3.03
Growth Ratio
Core Operating Income Growth 17.18 47.45 -28.33 -22.87 22.78
Operating Profit Growth 3.91 18.99 3.94 0.62 15.5
Net Profit Growth 2.48 6.36 36.16 -25.3 11.26
BVPS Growth 4.97 5.52 13.39 9.08 6.64
Advances Growth 0 0 0 0 0
EPS Growth(%) 1.16 8.23 40.05 -26.1 15.11
Liquidity Ratios
Loans/Deposits(x) 0 0 0 0 0
Total Debt/Equity(x) 0 0 0 0 0
Current Ratio(x) 0 0 0 0 0
Quick Ratio(x) 0 0 0 0 0
Interest Cover(x)
Total Debt/Mcap(x) 0 0 0 0 0
Net NPA in Rs. Million 0 0 0 0 0
Particulars Mar-2020 Mar-2019 Mar-2018 Mar-2017 Mar-2016
Operational & Financial Ratios
Earnings Per Share (Rs) 28.75 23.44 18.24 12.12 18.2
DPS(Rs) 4 3 3 2 2
Book NAV/Share(Rs) 100 100 100 100 100
Margin Ratios
Yield on Advances 0 0 0 0 0
Yield on Investments 0 0 0 0 0
Cost of Liabilities 0 0 0 0 0
NIM 0 0 0 0 0
Interest Spread 0 0 0 0 0
Performance Ratios
ROA(%) 11.94 10.65 9.01 6.33 9.13
ROE(%) 14 12.67 10.96 7.91 12.77
ROCE(%) 18.08 16.69 14.03 9.34 14.79
Efficiency Ratios
Cost Income Ratio 0 0 0 0 0
Core Cost Income Ratio 0 0 0 0 0
Operating Costs to Assets 0 0 0 0 0
Capital Adequacy
Basel I
Total CAR (Basel I) 0 0 0 0 0
Tier-1 (Basel I) 0 0 0 0 0
Tier-2 (Basel I) 0 0 0 0 0
Basel II
Total CAR (Basel II) 0 0 0 0 0
Tier-1 (Basel II) 0 0 0 0 0
Tier-2 (Basel II) 0 0 0 0 0
Basel III
Total CAR (Basel III) 0 0 0 0 0
Tier - 1 (Basel III) 0 0 0 0 0
Tier - 2 (Basel III) 0 0 0 0 0
Valuation Parameters
PER(x) 14.71 22.58 29.78 48.88 28.14
PCE(x) 11.76 17.4 21.89 32.31 21.6
Price/Book(x) 1.96 2.71 3.11 3.74 3.46
Yield(%) 0.95 0.57 0.55 0.34 0.39
EV/Net Sales(x) 2.65 3.43 3.84 4.45 3.53
EV/Core EBITDA(x) 9.38 13.83 17.26 27.76 18.1
EV/EBIT(x) 11.19 16.92 22.71 39.08 22.33
EV/CE(x) 1.65 2.31 2.56 3.08 2.77
M Cap / Sales 2.69 3.45 3.84 4.42 3.44
Growth Ratio
Core Operating Income Growth 100 42.61 -69.64 -73.35 8.1
Operating Profit Growth 16.58 21.4 46.6 -26.04 10.64
Net Profit Growth 22.76 28.59 50.63 -33.33 23.81
BVPS Growth 10.28 11.86 10.27 6.95 7.99
Advances Growth 0 0 0 0 0
EPS Growth(%) 22.67 28.5 50.51 -33.42 23.74
Liquidity Ratios
Loans/Deposits(x) 0 0 0 0 0
Total Debt/Equity(x) 0 0 0 0 0
Current Ratio(x) 0 0 0 0 0
Quick Ratio(x) 0 0 0 0 0
Interest Cover(x)
Total Debt/Mcap(x) 0 0 0 0 0
Net NPA in Rs. Million 0 0 0 0 0

Cash Flow

(₹ in Million)
Particulars Mar-2020 Mar-2019 Mar-2018 Mar-2017 Mar-2016
Net Profit Before Taxes 2.18 2.08 1.67 1.22 1.73
Adjustments for Expenses & Provisions : 1.37 1.27 1.29 1.37 0.95
Adjustments for Liabilities & Assets: 0.37 -1.06 -0.78 0.24 -0.43
Refund/(payment) of direct taxes -0.85 -0.59 -0.72 -0.45 -0.51
Other Direct payments 0 0 0 0 0
Cash Flow from operating activities 3.07 1.69 1.46 2.38 1.74
Cash Flow from investing activities 0.1 -1.67 -0.85 -1.31 -4.52
Cash Flow from financing activities -2.95 -0.35 -0.39 -1.33 3.1
Effect of exchange fluctuation on translation reserve 0 0 0 0 0
Net increase/(decrease) in cash and cash equivalents 0.22 -0.33 0.22 -0.25 0.32
Opening Cash & Cash Equivalents 0.51 0.85 0.61 0.86 0.55
Cash & Cash Equivalent on Amalgamation / Take over / Merger 0 0 0 0 0
Cash & Cash Equivalent of Subsidiaries under liquidations 0 0 0 0 0
Translation adjustment on reserves / op cash balalces frgn subsidiaries 0 0 0 0 0
Effect of Foreign Exchange Fluctuations 0.01 -0.02 0.02 0.01 -0.01
Closing Cash & Cash Equivalent 0.74 0.51 0.85 0.61 0.86
Cash & Cash Equivalent on Amalgamation / Take over / Merger 0 0 0 0 0
Cash & Cash Equivalent of Subsidiaries under liquidations 0 0 0 0 0
Translation adjustment on reserves / op cash balalces frgn subsidiaries 0 0 0 0 0
Effect of Foreign Exchange Fluctuations 0.01 -0.02 0.02 0.01 -0.01
(₹ in Million)
Particulars Mar-2020 Mar-2019 Mar-2018 Mar-2017 Mar-2016
Net Profit Before Taxes 2.18 2.08 1.67 1.22 1.73
Adjustments for Expenses & Provisions : 1.37 1.27 1.29 1.37 0.95
Adjustments for Liabilities & Assets: 0.37 -1.06 -0.78 0.24 -0.43
Refund/(payment) of direct taxes -0.85 -0.59 -0.72 -0.45 -0.51
Other Direct payments 0 0 0 0 0
Cash Flow from operating activities 3.07 1.69 1.46 2.38 1.74
Cash Flow from investing activities 0.1 -1.67 -0.85 -1.31 -4.52
Cash Flow from financing activities -2.95 -0.35 -0.39 -1.33 3.1
Effect of exchange fluctuation on translation reserve 0 0 0 0 0
Net increase/(decrease) in cash and cash equivalents 0.22 -0.33 0.22 -0.25 0.32
Opening Cash & Cash Equivalents 0.51 0.85 0.61 0.86 0.55
Cash & Cash Equivalent on Amalgamation / Take over / Merger 0 0 0 0 0
Cash & Cash Equivalent of Subsidiaries under liquidations 0 0 0 0 0
Translation adjustment on reserves / op cash balalces frgn subsidiaries 0 0 0 0 0
Effect of Foreign Exchange Fluctuations 0.01 -0.02 0.02 0.01 -0.01
Closing Cash & Cash Equivalent 0.74 0.51 0.85 0.61 0.86
Cash & Cash Equivalent on Amalgamation / Take over / Merger 0 0 0 0 0
Cash & Cash Equivalent of Subsidiaries under liquidations 0 0 0 0 0
Translation adjustment on reserves / op cash balalces frgn subsidiaries 0 0 0 0 0
Effect of Foreign Exchange Fluctuations 0.01 -0.02 0.02 0.01 -0.01

Share Price

Year Open Price (₹) High Price (₹) Low Price (₹) Close Price (₹) Volume (000's) Value (in Lakhs)
February-2021 818.5 878.55 785.55 849.3 2622.57 22124.41
January-2021 823.35 869.65 796.35 825.6 2917.68 24348.28
December-2020 750.35 838.95 746.65 823.65 4929.31 38917.63
November-2020 758 805 706.45 744.65 6503.64 48785.47
October-2020 771 829 742.5 754.1 5675.56 44339.12
September-2020 710.1 819 701.5 774.75 7819.36 59637.44
August-2020 725 814.45 700.9 712.1 8378.53 63789.08
Cipla jumps after its associate company incorporates wholly-owned subsidiary05-May-2021 02:53 PM  
Cipla’s associate company incorporates wholly-owned subsidiary04-May-2021 09:25 AM  
Cipla inches up on entering into licensing agreement with MSD29-Apr-2021 11:10 AM  
Cipla enters into licensing agreement with MSD 28-Apr-2021 03:43 PM  
Cipla informs about postal ballot notice24-Apr-2021 02:02 PM  
Cipla zooms after doubling Remdesivir production to meet 'unprecedented' demand15-Apr-2021 11:17 AM  
Cipla doubles Remdesivir production to meet 'unprecedented' demand13-Apr-2021 04:34 PM  
Cipla moves up on entering into agreement to become partner in ABCD Technologies LLP31-Mar-2021 01:40 PM  
Cipla enters into agreement to become partner in ABCD Technologies LLP31-Mar-2021 01:37 PM  
Cipla inches up as its affiliate enters into strategic partnership with SIGA Technologies23-Mar-2021 09:43 AM  
Cipla’s affiliate enters into strategic partnership with SIGA Technologies 23-Mar-2021 09:15 AM  
Cipla pledges support to ‘Terra Carta’ for sustainable future19-Mar-2021 09:39 AM  
Cipla informs about analyst meet08-Mar-2021 12:14 PM  
Cipla voluntarily liquidates wholly-owned step-down subsidiary08-Mar-2021 10:46 AM  
Cipla informs about liquidation06-Mar-2021 11:11 AM  
Cipla informs about analyst meet02-Mar-2021 11:51 AM  
Cipla informs about press release02-Mar-2021 10:35 AM  
Cipla gains on receiving USFDA’s final approval for Sumatriptan Nasal Spray02-Mar-2021 10:20 AM  
Cipla's arm expands partnership with Alvotech02-Mar-2021 09:45 AM  
Cipla receives USFDA’s final approval for Sumatriptan Nasal Spray02-Mar-2021 09:30 AM  
Cipla gains on reporting 2-fold jump in Q3 consolidated net profit02-Feb-2021 12:21 PM  
Cipla gains on reporting 2-fold jump in Q3 consolidated net profit02-Feb-2021 12:19 PM  
Cipla reports 2-fold jump in Q3 consolidated net profit01-Feb-2021 11:27 AM  
Cipla trades higher on the bourses11-Jan-2021 02:15 PM  
Cipla recalling over 5.8 lakh packets of gastric ulcer treatment drug in US11-Jan-2021 09:58 AM  
Cipla informs about disclosure22-Dec-2020 10:34 AM  
Cipla jumps as its step-down associate company gets regulatory update for intravenous tramadol18-Dec-2020 02:00 PM  
Cipla’s step-down associate company gets regulatory update for intravenous tramadol18-Dec-2020 01:34 PM  
Cipla informs about press release16-Dec-2020 10:25 AM  
Cipla inches up on entering into partnership with Premier Medical Corporation 16-Dec-2020 09:50 AM  
Cipla enters into partnership with Premier Medical Corporation 16-Dec-2020 09:13 AM  
Cipla informs about press release18-Nov-2020 10:31 AM  
Cipla gains on signing licensing agreement with Multi G18-Nov-2020 09:34 AM  
Cipla signs licensing agreement with Multi G18-Nov-2020 09:25 AM